Skip to main content
Clinical Trials/JPRN-UMIN000036507
JPRN-UMIN000036507Completed未知

Effect of sivelestat, a neutrophil elastase inhibitor on cardiac surgical patients after cardiopulmonary bypass - Effect of sivelestat, a neutrophil elastase inhibitor on cardiac surgical patients after cardiopulmonary bypass

ippon Medical School0 sites30 target enrollmentStarted: April 14, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

In the control group, the levels of PMN elastase, IL-6, IL-8 in BAL showed a increase after CPB initiation, and were maintained at high levels 3 hours after CPB. In contrast, the sivelestat group had lower concentrations of PMN elastase, IL-6, IL-8 during and after CPB. The reduction in PaO2/FiO2 ratio after CPB was strongly related to the increase in IL-8, IL-6 or the elevation in PMN elastase.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • shock, pulmonary edema, liver dysfunction

Investigators

Sponsor
ippon Medical School

Similar Trials